Neutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growth is a research paper published in Molecular Therapy — Methods & Clinical Development (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: F30 CA271624
NIAID NIH HHS
Grant: R01 AI150597
NCI NIH HHS
Grant: R21 CA231277
NCRR NIH HHS
Grant: S10 RR027050
NIH HHS
Grant: S10 OD020056
NIAID NIH HHS
Grant: R01 AI125640
National Institutes of Health
Grant: 1S10RR027050-01A1
Becton Dickinson LSR II Analytical Flow Cytometer
National Institutes of Health
Grant: 5R01AI125640-09
Novel mechanisms regulating PD-1 signaling and function
National Institutes of Health
Grant: 1S10OD020056-01
BD Biosciences Influx
National Institutes of Health
Grant: 1R21CA231277-01A1
(PQ8) Predictive biomarkers for the onset of immune-related adverse events associated with PD-1 blockade
National Institutes of Health
Grant: 5R01AI150597-04
PAG is a novel target in immunotherapy
FWCI
0.56
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals